Xpedite Diagnostics will be at the 200 Years Theodor Bilharz symposium in Tübingen, October 8–10, presenting new advances in schistosomiasis and field diagnostics. Meet our team to discuss rapid DNA/RNA extraction technologies that support better diagnostics and global health.
Six minutes. One step. PCR-ready. SwiftX™ Virus is now CE-IVD certified — delivering rapid, contamination-minimized DNA/RNA extraction for serum and plasma. Validated across six arboviruses and Leptospira with 98% sensitivity and 100% specificity, it’s the new standard for fast,…
Xpedite Diagnostics will be at ECTMIH 2025 in Hamburg, September 29–October 1, engaging with the global health community on molecular diagnostics for tropical medicine and infectious diseases.
New from MYK2025 (Cologne): a reverse-purification workflow that replaces multi-step spin-columns to deliver inhibitor-reduced, PCR-ready fungal DNA from skin, hair, and nails. The streamlined pre-analytics cuts sample-prep to ~30 minutes (vs ~60 with conventional methods) and…
Companion animals and polluted air may play a larger role in antimicrobial resistance than previously recognized. In this PREPARE-TID webinar, experts revealed new data on ESBL-producing E. coli in dogs and the hidden resistome of urban air.
A new protocol expands Myra’s role into nucleic acid extraction, offering faster, reproducible, and automated workflows for your lab. Learn more and download the protocol.
Xpedite Diagnostics will be at Myk2025 in Cologne, September 4–6, to present rapid nucleic acid extraction workflows for fungal diagnostics and dermatophytosis testing.
Emerging arboviruses and neglected bacterial zoonoses are reshaping Europe’s infectious disease landscape. This PREPARE-TID webinar examined molecular surveillance data on West Nile, Usutu, and avian influenza, alongside zoonotic threats such as brucellosis and Q fever. The…
Europe is facing a rising threat from vector-borne viruses like dengue, West Nile, and CCHF. In this PREPARE-TID webinar, leading experts discuss how rapid diagnostics and genomic surveillance can help detect outbreaks early and stop their spread.
